Skeleton slow releasing implant for deworming from dogs and its preparation method
A slow-release implant, skeleton-type technology, which is applied in the field of preparation in the field of pharmaceutical engineering technology, can solve the problems of high fluidity, waste of drugs, large workload, etc. cost reduction effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0019] (1) 200 mg of broad-spectrum echinococcosis drug mebendazole and 100 mg of histocompatibility material EVA (ethylene-vinyl acetate copolymer, vinyl acetate content is 33%) weighed in a ratio of 1:0.5;
[0020] (2) Drugs and materials were dissolved in 20ml of dichloromethane by shaking at room temperature;
[0021] (3) Evaporate dichloromethane at 30°C and 0.8MPa to form a solid mixture of drugs and materials;
[0022] (4) Mechanically pulverize the solid mixture and fill the pulverized mixture into a mold at 40° C., after it is completely melted, extrude under pressure or cool at room temperature to form, and demould.
[0023] Implementation effect: the implant prepared by the invention is used for preventing and treating canine echinococcosis, not only can reduce the cost of prevention and treatment by more than 50%, but also can release medicine steadily and slowly in the dog for 300-500 days.
Embodiment 2
[0025] (1) 200 mg of broad-spectrum echinococcosis drug praziquantel and 400 mg of histocompatibility material PLGA (polylactic acid-polyglycolic acid copolymer, the content ratio of polylactic acid and polyglycolic acid is 85:15) were weighed in a 1:2 ratio. );
[0026] (2) Drugs and materials were dissolved in 35ml of dichloromethane by shaking at room temperature;
[0027] (3) Evaporate dichloromethane at 20°C and 0.1MPa to form a solid mixture of drugs and materials;
[0028] (4) Mechanically pulverize the solid mixture of drugs and materials and fill the pulverized mixture into a mold at 110° C., and after it is completely melted, extrude under pressure or cool at room temperature to form, and demould.
[0029] Implementation effect: the implant prepared by the invention is used for preventing and treating canine echinococcosis, not only can reduce the cost of prevention and treatment by more than 50%, but also can release medicine steadily and slowly in the dog for 300-...
Embodiment 3
[0031] (1) 20 mg of broad-spectrum echinococcosis drug pyrantel pamoate and 600 mg of histocompatibility material PCL (polycaprolactone, weight average molecular weight 50,000) were weighed in a ratio of 1:30;
[0032] (2) Drugs and materials were dissolved in 50ml of chloroform by shaking at room temperature;
[0033] (3) Evaporate chloroform to form a solid mixture of drugs and materials under the conditions of 60°C and 0.99MPa;
[0034] (4) Mechanically pulverize the solid mixture of medicines and materials and fill the pulverized mixture into a mold at 90°C. After melting completely, extrude under pressure or cool at room temperature to form, and demould.
[0035] Implementation effect: the implant prepared by the invention is used for preventing and treating canine echinococcosis, not only can reduce the cost of prevention and treatment by more than 50%, but also can release medicine steadily and slowly in the dog for 300-500 days.
PUM
Property | Measurement | Unit |
---|---|---|
Melting temperature | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com